[15-065031] roche diagnostics corp:1106277
Ended Awarded Last action
- Contract number
- HHSN26100021
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $29,306
Award facts
- Opportunity
-
- N02RC4265685 Solicitation number
- Reagents for Ventana Benchmark Systems Award Notice · Posted Oct 2, 2014
- Contract value 100% obligated
- $29,305.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$3 | |
| Original award | $29,309 |
About this award
This federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, was made by the National Cancer Institute (NCI), a component of the Department of Health and Human Services. The $29,305.51 firm fixed-price delivery order contract, which does not have a set-aside designation, is for the provision of critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services.
Roche Diagnostics has held multiple General Services Administration (GSA) Schedule contracts and Indefinite Delivery Vehicles (IDVs) to provide laboratory instruments, reagents, and testing capabilities to various federal agencies, including the Department of Veterans Affairs, Department of Defense, and Indian Health Service. This particular award appears to be part of a larger NCI contract vehicle, as the award document references an existing Indefinite Delivery Contract (IDC) number. Through this and other federal contracts, Roche Diagnostics has supported the medical and laboratory needs of federal healthcare facilities, research centers, and military treatment facilities nationwide.
Quick answers
Who was awarded contract HHSN26100021?
HHSN26100021 was awarded to Roche Diagnostics Corporation by National Cancer Institute (National Institutes of Health) on September 22, 2015.
How much is contract HHSN26100021 worth?
The government has obligated $29,306 on HHSN26100021.
Is contract HHSN26100021 an order under another contract?
Yes. HHSN26100021 is a delivery order under HHSN261201500001I, an indefinite delivery contract.
Was contract HHSN26100021 competed?
The extent of competition for HHSN26100021 was not competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award